AI in Respiratory Diseases Market Size, Trend, Forecast Report 2026 to 2035
What is AI in Respiratory Diseases Market Size?
AI in Respiratory Diseases Market size is valued at USD 11.48 Bn in 2025 and is predicted to reach USD 150.77 Bn by the year 2035 at an 29.50% CAGR during the forecast period for 2026 to 2035.
AI in Respiratory Diseases Market Size, Share & Trends Analysis Report By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By Imaging Type (MRI, CT Scan, ePRO), By End-use (Hospital, Diagnostic Centers, Ambulatory Surgical centers, Others), By Region, And by Segment Forecasts, 2026 to 2035.
AI in Respiratory Diseases Market Key Takeaways:
|
AI is revolutionizing the field of respiratory diseases by aiding in early diagnosis, personalized treatment, and remote monitoring. It can analyze medical images, predict disease progression, and even assist in drug discovery. AI also helps patients manage conditions like asthma and COPD while monitoring air quality and providing real-time insights. These advancements hold promise for improving patient care and outcomes in respiratory health.
Clinical data, chest scans, lung pathology, and pulmonary function testing can all be used by AI to aid in the diagnosis and prognosis of pulmonary disorders. The advent of new digital tools drives market expansion, and fields like genomics, medical imaging, and electronic health records are contributing to an unprecedented explosion in the volume and complexity of healthcare-related data. Because of this explosive expansion, more and more clinically relevant applications based on AI have been developed.
Expert pulmonologists who have studied AI theory and practice will be in a strong position to exploit emerging career prospects in both clinical practice and academic research. This review aims to educate pulmonologists and other interested readers about artificial intelligence's potential applications in this field of medicine. The advancement of healthcare technology has led to an anticipated uptick in the use of AI in respiratory diseases.
However, several negative aspects seriously restrain the expansion of AI in the respiratory diseases market. Lack of knowledge and high cost are hindering the AI in respiratory diseases market growth. In addition, the COVID-19 pandemic has had a major effect on the market for providers of artificial intelligence in respiratory diseases medicine. Several factors have contributed to this effect. Genomics, diagnostics, drug development, and individualized treatment are just some of the areas where artificial intelligence technologies like deep learning and the processing of natural language have found use. During the recent COVID-19 epidemic, the value of AI in responding to medical emergencies and improving our understanding of complex diseases became clear.
Competitive Landscape
Some Major Key Players In The AI in Respiratory Diseases Market:
- ArtiQ
- Dectrocel Healthcare
- DeepMind Health
- GE Healthcare
- Icometrix
- Infervision
- Philips Healthcare
- PneumoWave
- Respiray
- Siemens Healthineers
- Swaasa AI
- THIRONA
- Verily
- VIDA Diagnostics Inc
- Zynnon
Market Segmentation:
The AI in respiratory diseases market is segmented based on the indication, imaging type, and end-use. As per the indication, the market is segmented into chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary infection. By imaging type, the market is segmented into MRI, CT Scan, and ePRO. According to end-use segment, the market is segmented into hospitals, diagnostic centres, ambulatory surgical centers, and others.
Based On The Imaging Type, The CT Scan AI In The Respiratory Diseases Segment Is Accounted As A Major Contributor To The AI In The Respiratory Diseases Market
The CT Scan AI in the respiratory diseases category is expected to hold a maximum global market share because it helps in the diagnosis of lung problems such as pneumonia, cancer, blood clots, and smoking-related damage.
The Diagnostic Centers Segment Witnessed Growth At A Rapid Rate
The diagnostic centers are expected to grow rapidly in the global AI in respiratory diseases market. The crucial role of diagnostic centers in the diagnosis of diseases at an early stage cannot be overstated. Early diagnosis is solution to the successful treatment of different diseases, including cancer, cardiovascular disease. Screening tests and preventative medical examinations are available at medical clinics that specialize in diagnosing and treating such conditions, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The North American AI In Respiratory Diseases Market Holds A Significant Revenue Share
The North American AI in respiratory diseases market activity is anticipated to record the largest market share in revenue in the near future. It can be attributed to the expansion of financial resources and time spent on R&D. As the need for innovative healthcare services grows, governments, institutions, and investors are pouring more money into projects that aim to apply artificial intelligence to the practice of respiratory disease medicine. The need for AI in Respiratory Diseases is anticipated to increase as a result of this region.
AI in Respiratory Diseases Market Report Scope:
| Report Attribute | Specifications |
| Market size value in 2025 | USD 11.48 Bn |
| Revenue Forecast in 2035 | USD 150.77 Bn |
| Growth Rate CAGR | CAGR of 29.50% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Indication, Imaging Type, End-Use |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia |
| Competitive Landscape | Siemens Healthineers, VIDA Diagnostics Inc,THIRONA, Infervision, icometrix. GE Healthcare, Philips Healthcare, Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of AI in Respiratory Diseases Market-
AI in Respiratory Diseases Market By Indication-
- Chronic Obstructive Pulmonary Disease
- Interstitial Lung Disease
- Pulmonary Infection
AI in Respiratory Diseases Market By Imaging Type -
- MRI
- CT Scan
- ePRO
AI in Respiratory Diseases Market By End-use -
- Hospital
- Diagnostic Centers
- Ambulatory Surgical centers
- Others
AI in Respiratory Diseases Market By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI in Respiratory Diseases Market expected to grow a 29.50% CAGR during the forecast period for 2026-2035.
Siemens Healthineers, VIDA Diagnostics Inc,THIRONA, Infervision, icometrix. GE Healthcare, Philips Healthcare
AI in respiratory diseases market is segmented based on the indication, imaging type, and end-use. As per the indication, the market is segmented into chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary infection.
North America region is leading the AI in respiratory diseases market.
AI in Respiratory Diseases Market size is valued at USD 11.48 Bn in 2025 and is predicted to reach USD 150.77 Bn by the year 2035.